ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
21.01
-0.42 (-1.96%)
Mar 30, 2026, 4:00 PM EDT - Market closed
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $928.68 million as of March 30, 2026. Its market cap has increased by 30.00% in one year.
Market Cap
928.68M
Enterprise Value
615.87M
1-Year Change
30.00%
Ranking
Category
Stock Price
$21.01
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $928.68M, an increase of 61.45%. That is a compound annual growth rate of 24.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 928.68M | 11.81% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenas BioPharma | 1.04B |
| EyePoint | 1.04B |
| AbCellera Biologics | 991.33M |
| KalVista Pharmaceuticals | 990.13M |
| CytomX Therapeutics | 977.12M |
| Compass Therapeutics | 938.26M |
| Xeris Biopharma Holdings | 931.13M |
| uniQure | 923.56M |